Document
false--12-29Q320190000200406100000000248000000227000000110000000033000000002000000000.902.640.952.801.001.0043200000004320000000311984300031198430000.002500.006500.011500.016500.01650.01950.02050.02250.02450.02450.026250.0290.02950.033750.0340.0350.03550.03550.036250.03700.03750.043750.04500.04500.04850.04950.05500.05850.05950.06730.0695440000000044000000004400000000440000000026000000140000009000000480000001040000007900000094000000500000005200000015500000034000000690000001100000000457519000488882000
0000200406
2018-12-31
2019-09-29
0000200406
jnj:A0.250NotesDue2022Member
2018-12-31
2019-09-29
0000200406
jnj:A4.75NotesDue2019Member
2018-12-31
2019-09-29
0000200406
us-gaap:CommonStockMember
2018-12-31
2019-09-29
0000200406
jnj:A5.50NotesDue2024Member
2018-12-31
2019-09-29
0000200406
jnj:A0.650NotesDue2024Member
2018-12-31
2019-09-29
0000200406
jnj:A1.150NotesDue2028Member
2018-12-31
2019-09-29
0000200406
jnj:A1.650NotesDue2035Member
2018-12-31
2019-09-29
0000200406
2019-10-22
0000200406
2018-12-30
0000200406
2019-09-29
0000200406
2018-07-02
2018-09-30
0000200406
2019-07-01
2019-09-29
0000200406
2018-01-01
2018-09-30
0000200406
us-gaap:RetainedEarningsMember
2018-12-31
2019-09-29
0000200406
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-12-30
0000200406
us-gaap:TreasuryStockMember
2018-12-30
0000200406
us-gaap:TreasuryStockMember
2019-09-29
0000200406
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-09-29
0000200406
us-gaap:TreasuryStockMember
2018-12-31
2019-09-29
0000200406
us-gaap:RetainedEarningsMember
2018-12-30
0000200406
us-gaap:CommonStockMember
2018-12-30
0000200406
us-gaap:CommonStockMember
2019-09-29
0000200406
us-gaap:RetainedEarningsMember
2019-09-29
0000200406
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-12-31
2019-09-29
0000200406
us-gaap:RetainedEarningsMember
2017-12-31
0000200406
us-gaap:RetainedEarningsMember
2018-01-01
2018-09-30
0000200406
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-01-01
2018-09-30
0000200406
2018-09-30
0000200406
us-gaap:TreasuryStockMember
2018-01-01
2018-09-30
0000200406
us-gaap:TreasuryStockMember
2017-12-31
0000200406
2017-12-31
0000200406
us-gaap:CommonStockMember
2018-09-30
0000200406
us-gaap:TreasuryStockMember
2018-09-30
0000200406
us-gaap:CommonStockMember
2017-12-31
0000200406
us-gaap:RetainedEarningsMember
2018-09-30
0000200406
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2017-12-31
0000200406
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-09-30
0000200406
us-gaap:RetainedEarningsMember
2019-07-01
2019-09-29
0000200406
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-07-01
2019-09-29
0000200406
us-gaap:TreasuryStockMember
2019-06-30
0000200406
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-06-30
0000200406
2019-06-30
0000200406
us-gaap:TreasuryStockMember
2019-07-01
2019-09-29
0000200406
us-gaap:CommonStockMember
2019-06-30
0000200406
us-gaap:RetainedEarningsMember
2019-06-30
0000200406
us-gaap:RetainedEarningsMember
2018-07-02
2018-09-30
0000200406
us-gaap:TreasuryStockMember
2018-07-02
2018-09-30
0000200406
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-07-01
0000200406
us-gaap:TreasuryStockMember
2018-07-01
0000200406
us-gaap:CommonStockMember
2018-07-01
0000200406
us-gaap:RetainedEarningsMember
2018-07-01
0000200406
2018-07-01
0000200406
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-07-02
2018-09-30
0000200406
srt:MaximumMember
us-gaap:AccountingStandardsUpdate201602Member
2019-09-29
0000200406
srt:MinimumMember
us-gaap:AccountingStandardsUpdate201602Member
2019-09-29
0000200406
us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember
jnj:SupplyChainMember
2019-09-29
0000200406
us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember
jnj:AdvancedSterilizationProductsMember
2018-12-30
0000200406
us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember
jnj:SupplyChainMember
2018-12-30
0000200406
jnj:MedicalDevicesMember
2019-09-29
0000200406
jnj:ConsumerMember
2018-12-30
0000200406
jnj:PharmaceuticalMember
2019-09-29
0000200406
jnj:MedicalDevicesMember
2018-12-31
2019-09-29
0000200406
jnj:ConsumerMember
2018-12-31
2019-09-29
0000200406
jnj:MedicalDevicesMember
2018-12-30
0000200406
jnj:PharmaceuticalMember
2018-12-31
2019-09-29
0000200406
jnj:ConsumerMember
2019-09-29
0000200406
jnj:PharmaceuticalMember
2018-12-30
0000200406
jnj:PatentsAndTrademarksMember
2019-09-29
0000200406
us-gaap:TrademarksMember
2019-09-29
0000200406
us-gaap:OtherIntangibleAssetsMember
2019-09-29
0000200406
jnj:PurchasedInProcessResearchAndDevelopmentMember
2019-09-29
0000200406
us-gaap:OtherIntangibleAssetsMember
2018-12-30
0000200406
jnj:PatentsAndTrademarksMember
2018-12-30
0000200406
us-gaap:TrademarksMember
2018-12-30
0000200406
jnj:PurchasedInProcessResearchAndDevelopmentMember
2018-12-30
0000200406
jnj:AliosBiopharmaIncMember
jnj:PurchasedInProcessResearchAndDevelopmentMember
2018-07-02
2018-09-30
0000200406
jnj:AliosBiopharmaIncMember
jnj:PurchasedInProcessResearchAndDevelopmentMember
2018-12-31
2019-03-31
0000200406
us-gaap:OtherIntangibleAssetsMember
2018-12-31
2019-09-29
0000200406
jnj:PatentsAndTrademarksMember
2018-12-31
2019-09-29
0000200406
jnj:AurisHealthMember
jnj:PurchasedInProcessResearchAndDevelopmentMember
2019-06-30
0000200406
jnj:CurrentPortionofLongtermDebtMember
2019-09-29
0000200406
jnj:CurrentPortionofLongtermDebtMember
2018-12-30
0000200406
us-gaap:LongTermDebtMember
2018-12-30
0000200406
us-gaap:LongTermDebtMember
2019-09-29
0000200406
us-gaap:AvailableforsaleSecuritiesMember
us-gaap:CorporateDebtSecuritiesMember
2019-09-29
0000200406
us-gaap:HeldtomaturitySecuritiesMember
us-gaap:SovereignDebtSecuritiesMember
2019-09-29
0000200406
us-gaap:AvailableforsaleSecuritiesMember
us-gaap:SovereignDebtSecuritiesMember
2019-09-29
0000200406
us-gaap:AvailableforsaleSecuritiesMember
us-gaap:USTreasuryAndGovernmentMember
2019-09-29
0000200406
us-gaap:HeldtomaturitySecuritiesMember
us-gaap:SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember
2019-09-29
0000200406
us-gaap:HeldtomaturitySecuritiesMember
2019-09-29
0000200406
us-gaap:HeldtomaturitySecuritiesMember
us-gaap:CashMember
2019-09-29
0000200406
us-gaap:HeldtomaturitySecuritiesMember
us-gaap:BankTimeDepositsMember
2019-09-29
0000200406
us-gaap:AvailableforsaleSecuritiesMember
2019-09-29
0000200406
us-gaap:HeldtomaturitySecuritiesMember
us-gaap:CorporateDebtSecuritiesMember
2019-09-29
0000200406
us-gaap:HeldtomaturitySecuritiesMember
jnj:OtherReverseRepurchaseAgreementsMember
2019-09-29
0000200406
us-gaap:HeldtomaturitySecuritiesMember
us-gaap:MoneyMarketFundsMember
2019-09-29
0000200406
jnj:A3.375Notesdue2023Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A3.75Notesdue2047Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A5.95Notesdue2037Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A1.950Notesdue2020Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A3.55Notesdue2021Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A6.73Debenturesdue2023Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A5.85Debenturesdue2038Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A2.05Notesdue2023Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A0.650NotesDue2024Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A2.25Notesdue2022Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A2.45Notesdue2021Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A1.650NotesDue2035Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A3.55Notesdue2021Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A1.150NotesDue2028Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A3.70Notesdue2046Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A1.65Notesdue2021Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A1.150NotesDue2028Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A2.45Notesdue2021Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A4.50Notesdue2043Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A3.55Notesdue2036Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A4.50Debenturesdue2040Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A4.95Debenturesdue2033Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A2.900Notesdue2028Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A3.55Notesdue2036Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A2.45Notesdue2026Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A4.85Notesdue2041Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A2.625Notesdue2025Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:NotesDuePeriodFifteenMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:NotesDuePeriodFifteenMember
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A3.400Notesdue2038Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A3.625Notesdue2037Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A1.650NotesDue2035Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A5.95Notesdue2037Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A4.50Debenturesdue2040Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A6.95Notesdue2029Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A3.625Notesdue2037Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A3.375Notesdue2023Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A3.400Notesdue2038Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A4.375Notesdue2033Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A2.900Notesdue2028Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A3.500Notesdue2048Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A5.50NotesDue2024Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A2.95Notesdue2027Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A6.73Debenturesdue2023Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A4.95Debenturesdue2033Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A2.45Notesdue2026Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A0.250NotesDue2022Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A2.25Notesdue2022Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A1.65Notesdue2021Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A3.75Notesdue2047Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A0.250NotesDue2022Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A2.05Notesdue2023Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A1.950Notesdue2020Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A3.70Notesdue2046Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A4.375Notesdue2033Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A4.50Notesdue2043Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A4.85Notesdue2041Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A0.650NotesDue2024Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A5.50NotesDue2024Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A5.85Debenturesdue2038Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A6.95Notesdue2029Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
jnj:A2.625Notesdue2025Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A3.500Notesdue2048Member
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-09-29
0000200406
jnj:A2.95Notesdue2027Member
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-09-29
0000200406
us-gaap:EquitySecuritiesMember
jnj:EquityInvestmentswithoutReadilyDeterminableValueMember
2019-09-29
0000200406
us-gaap:EquitySecuritiesMember
jnj:EquityInvestmentswithReadilyDeterminableValueMember
2018-12-31
2019-09-29
0000200406
us-gaap:EquitySecuritiesMember
jnj:EquityInvestmentswithReadilyDeterminableValueMember
2019-09-29
0000200406
us-gaap:EquitySecuritiesMember
jnj:EquityInvestmentswithReadilyDeterminableValueMember
2018-12-30
0000200406
us-gaap:EquitySecuritiesMember
jnj:EquityInvestmentswithoutReadilyDeterminableValueMember
2018-12-30
0000200406
us-gaap:EquitySecuritiesMember
jnj:EquityInvestmentswithoutReadilyDeterminableValueMember
2018-12-31
2019-09-29
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
2019-09-29
0000200406
2018-01-01
2018-12-30
0000200406
us-gaap:OtherNoncurrentLiabilitiesMember
2018-12-30
0000200406
us-gaap:FairValueInputsLevel3Member
2018-12-30
0000200406
us-gaap:OtherNoncurrentLiabilitiesMember
2019-09-29
0000200406
us-gaap:EquitySecuritiesMember
2019-09-29
0000200406
us-gaap:FairValueInputsLevel1Member
2018-12-30
0000200406
us-gaap:InterestRateContractMember
2018-12-30
0000200406
us-gaap:ForeignExchangeContractMember
2018-12-30
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
2018-12-30
0000200406
us-gaap:InterestRateContractMember
2019-09-29
0000200406
us-gaap:ForeignExchangeContractMember
2019-09-29
0000200406
us-gaap:EquitySecuritiesMember
2018-12-30
0000200406
us-gaap:OtherCurrentLiabilitiesMember
2019-09-29
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueInputsLevel2Member
2018-12-30
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueInputsLevel1Member
2019-09-29
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueInputsLevel3Member
2019-09-29
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueInputsLevel1Member
2019-09-29
0000200406
us-gaap:FairValueInputsLevel3Member
2019-09-29
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueInputsLevel2Member
2019-09-29
0000200406
us-gaap:FairValueInputsLevel2Member
2019-09-29
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueInputsLevel3Member
2019-09-29
0000200406
us-gaap:FairValueInputsLevel1Member
2019-09-29
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueInputsLevel2Member
2018-12-30
0000200406
us-gaap:FairValueInputsLevel2Member
2018-12-30
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueInputsLevel2Member
2019-09-29
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:CostOfSalesMember
2019-07-01
2019-09-29
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
jnj:InterestIncomeExpenseNetMember
2018-07-02
2018-09-30
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:SalesMember
2019-07-01
2019-09-29
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:SalesMember
2018-07-02
2018-09-30
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:FairValueHedgingMember
jnj:InterestIncomeExpenseNetMember
2019-07-01
2019-09-29
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
jnj:OtherIncomeExpenseNetMember
2018-07-02
2018-09-30
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:SalesMember
2018-07-02
2018-09-30
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
us-gaap:ResearchAndDevelopmentExpenseMember
2019-07-01
2019-09-29
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
us-gaap:SalesMember
2019-07-01
2019-09-29
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
jnj:OtherIncomeExpenseNetMember
2019-07-01
2019-09-29
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
jnj:InterestIncomeExpenseNetMember
2018-07-02
2018-09-30
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
us-gaap:SalesMember
2018-07-02
2018-09-30
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:FairValueHedgingMember
jnj:OtherIncomeExpenseNetMember
2018-07-02
2018-09-30
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
jnj:InterestIncomeExpenseNetMember
2019-07-01
2019-09-29
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
jnj:OtherIncomeExpenseNetMember
2018-07-02
2018-09-30
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:FairValueHedgingMember
jnj:OtherIncomeExpenseNetMember
2019-07-01
2019-09-29
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
jnj:OtherIncomeExpenseNetMember
2018-07-02
2018-09-30
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
jnj:InterestIncomeExpenseNetMember
2019-07-01
2019-09-29
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
us-gaap:CostOfSalesMember
2019-07-01
2019-09-29
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
us-gaap:SalesMember
2019-07-01
2019-09-29
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
jnj:InterestIncomeExpenseNetMember
2019-07-01
2019-09-29
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
jnj:InterestIncomeExpenseNetMember
2018-07-02
2018-09-30
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:ResearchAndDevelopmentExpenseMember
2019-07-01
2019-09-29
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:CostOfSalesMember
2018-07-02
2018-09-30
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
us-gaap:CostOfSalesMember
2018-07-02
2018-09-30
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:SalesMember
2019-07-01
2019-09-29
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
jnj:OtherIncomeExpenseNetMember
2019-07-01
2019-09-29
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:CostOfSalesMember
2019-07-01
2019-09-29
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
us-gaap:ResearchAndDevelopmentExpenseMember
2019-07-01
2019-09-29
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
us-gaap:CostOfSalesMember
2019-07-01
2019-09-29
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:ResearchAndDevelopmentExpenseMember
2019-07-01
2019-09-29
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:ResearchAndDevelopmentExpenseMember
2019-07-01
2019-09-29
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:FairValueHedgingMember
jnj:InterestIncomeExpenseNetMember
2018-07-02
2018-09-30
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
us-gaap:ResearchAndDevelopmentExpenseMember
2018-07-02
2018-09-30
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
jnj:OtherIncomeExpenseNetMember
2019-07-01
2019-09-29
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:CostOfSalesMember
2018-07-02
2018-09-30
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
us-gaap:ResearchAndDevelopmentExpenseMember
2018-07-02
2018-09-30
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:CostOfSalesMember
2019-07-01
2019-09-29
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:ResearchAndDevelopmentExpenseMember
2018-07-02
2018-09-30
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
jnj:InterestIncomeExpenseNetMember
2018-07-02
2018-09-30
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:ResearchAndDevelopmentExpenseMember
2018-07-02
2018-09-30
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
us-gaap:SalesMember
2018-07-02
2018-09-30
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
jnj:OtherIncomeExpenseNetMember
2018-07-02
2018-09-30
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:CostOfSalesMember
2018-07-02
2018-09-30
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:SalesMember
2018-07-02
2018-09-30
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:ResearchAndDevelopmentExpenseMember
2018-07-02
2018-09-30
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:SalesMember
2019-07-01
2019-09-29
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
us-gaap:CostOfSalesMember
2018-07-02
2018-09-30
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
jnj:InterestIncomeExpenseNetMember
2019-07-01
2019-09-29
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
jnj:OtherIncomeExpenseNetMember
2019-07-01
2019-09-29
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
jnj:OtherIncomeExpenseNetMember
2018-01-01
2018-09-30
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
jnj:InterestIncomeExpenseNetMember
2018-01-01
2018-09-30
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
us-gaap:SalesMember
2018-01-01
2018-09-30
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
jnj:InterestIncomeExpenseNetMember
2018-01-01
2018-09-30
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:FairValueHedgingMember
jnj:OtherIncomeExpenseNetMember
2018-12-31
2019-09-29
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:FairValueHedgingMember
jnj:OtherIncomeExpenseNetMember
2018-01-01
2018-09-30
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
jnj:OtherIncomeExpenseNetMember
2018-12-31
2019-09-29
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
jnj:OtherIncomeExpenseNetMember
2018-12-31
2019-09-29
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
us-gaap:ResearchAndDevelopmentExpenseMember
2018-12-31
2019-09-29
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
us-gaap:SalesMember
2018-01-01
2018-09-30
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:SalesMember
2018-01-01
2018-09-30
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:SalesMember
2018-01-01
2018-09-30
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
us-gaap:SalesMember
2018-12-31
2019-09-29
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
jnj:InterestIncomeExpenseNetMember
2018-01-01
2018-09-30
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
us-gaap:ResearchAndDevelopmentExpenseMember
2018-01-01
2018-09-30
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:ResearchAndDevelopmentExpenseMember
2018-12-31
2019-09-29
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
us-gaap:CostOfSalesMember
2018-01-01
2018-09-30
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:FairValueHedgingMember
jnj:InterestIncomeExpenseNetMember
2018-01-01
2018-09-30
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
jnj:OtherIncomeExpenseNetMember
2018-12-31
2019-09-29
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:ResearchAndDevelopmentExpenseMember
2018-12-31
2019-09-29
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:ResearchAndDevelopmentExpenseMember
2018-01-01
2018-09-30
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:FairValueHedgingMember
jnj:InterestIncomeExpenseNetMember
2018-12-31
2019-09-29
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
jnj:OtherIncomeExpenseNetMember
2018-01-01
2018-09-30
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
us-gaap:CostOfSalesMember
2018-01-01
2018-09-30
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
us-gaap:ResearchAndDevelopmentExpenseMember
2018-01-01
2018-09-30
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
jnj:InterestIncomeExpenseNetMember
2018-12-31
2019-09-29
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:SalesMember
2018-12-31
2019-09-29
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:CostOfSalesMember
2018-01-01
2018-09-30
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:ResearchAndDevelopmentExpenseMember
2018-12-31
2019-09-29
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
us-gaap:ResearchAndDevelopmentExpenseMember
2018-12-31
2019-09-29
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
jnj:OtherIncomeExpenseNetMember
2018-01-01
2018-09-30
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
us-gaap:SalesMember
2018-12-31
2019-09-29
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:CostOfSalesMember
2018-12-31
2019-09-29
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:CostOfSalesMember
2018-01-01
2018-09-30
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:SalesMember
2018-12-31
2019-09-29
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:CostOfSalesMember
2018-01-01
2018-09-30
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:CostOfSalesMember
2018-12-31
2019-09-29
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
jnj:OtherIncomeExpenseNetMember
2018-12-31
2019-09-29
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
jnj:InterestIncomeExpenseNetMember
2018-12-31
2019-09-29
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:ResearchAndDevelopmentExpenseMember
2018-01-01
2018-09-30
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
jnj:InterestIncomeExpenseNetMember
2018-12-31
2019-09-29
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
us-gaap:CashFlowHedgingMember
us-gaap:CostOfSalesMember
2018-12-31
2019-09-29
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:SalesMember
2018-01-01
2018-09-30
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
jnj:InterestIncomeExpenseNetMember
2018-12-31
2019-09-29
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
us-gaap:CostOfSalesMember
2018-12-31
2019-09-29
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:SalesMember
2018-12-31
2019-09-29
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
jnj:InterestIncomeExpenseNetMember
2018-01-01
2018-09-30
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
jnj:OtherIncomeExpenseNetMember
2018-01-01
2018-09-30
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:ResearchAndDevelopmentExpenseMember
2018-01-01
2018-09-30
0000200406
us-gaap:InterestRateContractMember
us-gaap:FairValueHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:CostOfSalesMember
2018-12-31
2019-09-29
0000200406
us-gaap:SaleOfSubsidiaryGainLossMember
2018-01-01
2018-09-30
0000200406
us-gaap:SaleOfSubsidiaryGainLossMember
2018-12-31
2019-09-29
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
2018-01-01
2018-09-30
0000200406
jnj:OtherIncomeExpenseNetMember
2018-12-31
2019-09-29
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
2018-12-31
2019-09-29
0000200406
jnj:OtherIncomeExpenseNetMember
2018-01-01
2018-09-30
0000200406
jnj:OtherIncomeExpenseNetMember
2019-07-01
2019-09-29
0000200406
jnj:OtherIncomeExpenseNetMember
2018-07-02
2018-09-30
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
2018-07-02
2018-09-30
0000200406
us-gaap:CrossCurrencyInterestRateContractMember
2019-07-01
2019-09-29
0000200406
us-gaap:SaleOfSubsidiaryGainLossMember
2019-07-01
2019-09-29
0000200406
us-gaap:SaleOfSubsidiaryGainLossMember
2018-07-02
2018-09-30
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
jnj:OtherIncomeExpenseNetMember
2018-01-01
2018-09-30
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
jnj:OtherIncomeExpenseNetMember
2018-07-02
2018-09-30
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
jnj:OtherIncomeExpenseNetMember
2018-12-31
2019-09-29
0000200406
us-gaap:ForeignExchangeContractMember
us-gaap:NondesignatedMember
jnj:OtherIncomeExpenseNetMember
2019-07-01
2019-09-29
0000200406
jnj:A4.50Notesdue2043Member
2019-09-29
0000200406
jnj:A2.25Notesdue2022Member
2019-09-29
0000200406
jnj:A4.50Debenturesdue2040Member
2019-09-29
0000200406
jnj:A3.55Notesdue2021Member
2019-09-29
0000200406
jnj:A0.250NotesDue2022Member
2019-09-29
0000200406
jnj:A1.150NotesDue2028Member
2019-09-29
0000200406
jnj:A4.95Debenturesdue2033Member
2019-09-29
0000200406
jnj:A6.95Notesdue2029Member
2019-09-29
0000200406
jnj:A2.05Notesdue2023Member
2019-09-29
0000200406
jnj:A0.650NotesDue2024Member
2019-09-29
0000200406
jnj:A3.375Notesdue2023Member
2019-09-29
0000200406
jnj:A3.400Notesdue2038Member
2019-09-29
0000200406
jnj:A2.625Notesdue2025Member
2019-09-29
0000200406
jnj:A3.500Notesdue2048Member
2019-09-29
0000200406
jnj:A4.375Notesdue2033Member
2019-09-29
0000200406
jnj:A5.95Notesdue2037Member
2019-09-29
0000200406
jnj:A1.65Notesdue2021Member
2019-09-29
0000200406
jnj:A3.75Notesdue2047Member
2019-09-29
0000200406
jnj:A2.45Notesdue2026Member
2019-09-29
0000200406
jnj:A4.85Notesdue2041Member
2019-09-29
0000200406
jnj:A3.625Notesdue2037Member
2019-09-29
0000200406
jnj:A2.900Notesdue2028Member
2019-09-29
0000200406
jnj:A3.70Notesdue2046Member
2019-09-29
0000200406
jnj:A1.650NotesDue2035Member
2019-09-29
0000200406
jnj:A3.55Notesdue2036Member
2019-09-29
0000200406
jnj:A5.85Debenturesdue2038Member
2019-09-29
0000200406
jnj:A5.50NotesDue2024Member
2019-09-29
0000200406
jnj:A2.95Notesdue2027Member
2019-09-29
0000200406
jnj:A2.45Notesdue2021Member
2019-09-29
0000200406
jnj:A6.73Debenturesdue2023Member
2019-09-29
0000200406
jnj:A1.950Notesdue2020Member
2019-09-29
0000200406
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2018-07-02
2018-09-30
0000200406
us-gaap:PensionPlansDefinedBenefitMember
2018-01-01
2018-09-30
0000200406
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2018-12-31
2019-09-29
0000200406
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2019-07-01
2019-09-29
0000200406
us-gaap:PensionPlansDefinedBenefitMember
2019-07-01
2019-09-29
0000200406
us-gaap:PensionPlansDefinedBenefitMember
2018-12-31
2019-09-29
0000200406
us-gaap:PensionPlansDefinedBenefitMember
2018-07-02
2018-09-30
0000200406
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2018-01-01
2018-09-30
0000200406
us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember
2018-12-31
2019-09-29
0000200406
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2019-09-29
0000200406
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2018-12-30
0000200406
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2019-09-29
0000200406
us-gaap:AccumulatedTranslationAdjustmentMember
2018-12-30
0000200406
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2018-12-30
0000200406
us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember
2019-09-29
0000200406
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2018-12-31
2019-09-29
0000200406
us-gaap:AccumulatedTranslationAdjustmentMember
2019-09-29
0000200406
us-gaap:AccumulatedTranslationAdjustmentMember
2018-12-31
2019-09-29
0000200406
us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember
2018-12-31
2019-09-29
0000200406
us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember
2018-12-30
0000200406
us-gaap:OperatingSegmentsMember
jnj:MedicalDevicesMember
2019-07-01
2019-09-29
0000200406
us-gaap:OperatingSegmentsMember
jnj:PharmaceuticalMember
2018-01-01
2018-09-30
0000200406
us-gaap:OperatingSegmentsMember
2018-07-02
2018-09-30
0000200406
us-gaap:CorporateNonSegmentMember
2018-01-01
2018-09-30
0000200406
us-gaap:OperatingSegmentsMember
jnj:ConsumerMember
2018-12-31
2019-09-29
0000200406
us-gaap:OperatingSegmentsMember
jnj:PharmaceuticalMember
2018-12-31
2019-09-29
0000200406
us-gaap:OperatingSegmentsMember
2018-01-01
2018-09-30
0000200406
us-gaap:OperatingSegmentsMember
jnj:ConsumerMember
2018-01-01
2018-09-30
0000200406
us-gaap:OperatingSegmentsMember
jnj:ConsumerMember
2019-07-01
2019-09-29
0000200406
us-gaap:OperatingSegmentsMember
2019-07-01
2019-09-29
0000200406
us-gaap:OperatingSegmentsMember
jnj:ConsumerMember
2018-07-02
2018-09-30
0000200406
us-gaap:CorporateNonSegmentMember
2019-07-01
2019-09-29
0000200406
us-gaap:CorporateNonSegmentMember
2018-12-31
2019-09-29
0000200406
us-gaap:OperatingSegmentsMember
jnj:MedicalDevicesMember
2018-07-02
2018-09-30
0000200406
us-gaap:OperatingSegmentsMember
2018-12-31
2019-09-29
0000200406
us-gaap:CorporateNonSegmentMember
2018-07-02
2018-09-30
0000200406
us-gaap:OperatingSegmentsMember
jnj:MedicalDevicesMember
2018-01-01
2018-09-30
0000200406
us-gaap:OperatingSegmentsMember
jnj:PharmaceuticalMember
2018-07-02
2018-09-30
0000200406
us-gaap:OperatingSegmentsMember
jnj:PharmaceuticalMember
2019-07-01
2019-09-29
0000200406
us-gaap:OperatingSegmentsMember
jnj:MedicalDevicesMember
2018-12-31
2019-09-29
0000200406
jnj:DARZALEXMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-12-31
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-07-02
2018-09-30
0000200406
jnj:SimponiSimponiAriaMember
country:US
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-07-02
2018-09-30
0000200406
jnj:IMBRUVICAMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-01-01
2018-09-30
0000200406
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-12-31
2019-09-29
0000200406
jnj:OtherMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2019-07-01
2019-09-29
0000200406
jnj:WoundCareandOtherMember
us-gaap:NonUsMember
jnj:ConsumerMember
2018-12-31
2019-09-29
0000200406
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-07-02
2018-09-30
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-07-02
2018-09-30
0000200406
country:US
jnj:MedicalDevicesMember
jnj:DiabetesCareMember
2018-01-01
2018-09-30
0000200406
jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember
country:US
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-07-02
2018-09-30
0000200406
jnj:TremfyaMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-07-02
2018-09-30
0000200406
jnj:INVOKANAINVOKAMETMember
country:US
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2019-07-01
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:ConsumerMember
2018-01-01
2018-09-30
0000200406
jnj:SPECIALTYMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-01-01
2018-09-30
0000200406
jnj:OtherMember
country:US
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-01-01
2018-09-30
0000200406
jnj:ZYTIGAMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2019-07-01
2019-09-29
0000200406
jnj:OtherImmunologyMember
country:US
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-12-31
2019-09-29
0000200406
jnj:OtherOncologyMember
country:US
jnj:PharmaceuticalMember
jnj:OncologyMember
2019-07-01
2019-09-29
0000200406
jnj:TRACLEERMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2019-07-01
2019-09-29
0000200406
jnj:WoundCareandOtherMember
country:US
jnj:ConsumerMember
2018-12-31
2019-09-29
0000200406
jnj:SURGICALMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:VisionMember
2018-01-01
2018-09-30
0000200406
jnj:OralCareMember
country:US
jnj:ConsumerMember
2019-07-01
2019-09-29
0000200406
jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-07-02
2018-09-30
0000200406
jnj:SURGICALMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:VisionMember
2018-12-31
2019-09-29
0000200406
jnj:OTHERNEUROSCIENCEMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2019-07-01
2019-09-29
0000200406
jnj:SPINEOTHERMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-01-01
2018-09-30
0000200406
country:US
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-07-02
2018-09-30
0000200406
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-07-02
2018-09-30
0000200406
jnj:MedicalDevicesMember
jnj:InterventionalSolutionsMember
2019-07-01
2019-09-29
0000200406
jnj:BabyCareMember
jnj:ConsumerMember
2018-07-02
2018-09-30
0000200406
jnj:OTHERNEUROSCIENCEMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-12-31
2019-09-29
0000200406
jnj:XareltoMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-07-02
2018-09-30
0000200406
jnj:OtherImmunologyMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-12-31
2019-09-29
0000200406
jnj:StelaraMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-01-01
2018-09-30
0000200406
jnj:RemicadeMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2019-07-01
2019-09-29
0000200406
jnj:PROCRITEPREXMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2019-07-01
2019-09-29
0000200406
jnj:OtherOncologyMember
country:US
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-12-31
2019-09-29
0000200406
jnj:GENERALMember
country:US
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-12-31
2019-09-29
0000200406
jnj:BeautyMember
country:US
jnj:ConsumerMember
2018-12-31
2019-09-29
0000200406
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-01-01
2018-09-30
0000200406
jnj:XareltoMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2019-07-01
2019-09-29
0000200406
jnj:OtherImmunologyMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2019-07-01
2019-09-29
0000200406
jnj:SPINEOTHERMember
country:US
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-07-02
2018-09-30
0000200406
jnj:SURGICALMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:VisionMember
2018-07-02
2018-09-30
0000200406
jnj:HIPSMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-01-01
2018-09-30
0000200406
us-gaap:NonUsMember
jnj:ConsumerMember
2018-12-31
2019-09-29
0000200406
jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-12-31
2019-09-29
0000200406
country:US
jnj:MedicalDevicesMember
2018-12-31
2019-09-29
0000200406
jnj:ADVANCEDMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-12-31
2019-09-29
0000200406
jnj:SimponiSimponiAriaMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2019-07-01
2019-09-29
0000200406
jnj:OPSUMITMember
country:US
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-07-02
2018-09-30
0000200406
jnj:IMBRUVICAMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-01-01
2018-09-30
0000200406
jnj:OtherImmunologyMember
country:US
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-07-02
2018-09-30
0000200406
jnj:SPECIALTYMember
country:US
jnj:MedicalDevicesMember
jnj:SurgeryMember
2019-07-01
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2019-07-01
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2019-07-01
2019-09-29
0000200406
jnj:IMBRUVICAMember
country:US
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-12-31
2019-09-29
0000200406
jnj:SPINEOTHERMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-12-31
2019-09-29
0000200406
country:US
jnj:MedicalDevicesMember
jnj:SurgeryMember
2019-07-01
2019-09-29
0000200406
jnj:BabyCareMember
us-gaap:NonUsMember
jnj:ConsumerMember
2019-07-01
2019-09-29
0000200406
jnj:OtherInfectiousDiseasesMember
country:US
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-07-02
2018-09-30
0000200406
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:DiabetesCareMember
2018-12-31
2019-09-29
0000200406
jnj:TRAUMAMember
country:US
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-01-01
2018-09-30
0000200406
jnj:CONTACTLENSESOTHERMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:VisionMember
2019-07-01
2019-09-29
0000200406
jnj:GENERALMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-12-31
2019-09-29
0000200406
jnj:OtherMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-12-31
2019-09-29
0000200406
jnj:IMBRUVICAMember
country:US
jnj:PharmaceuticalMember
jnj:OncologyMember
2019-07-01
2019-09-29
0000200406
jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember
country:US
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-01-01
2018-09-30
0000200406
jnj:StelaraMember
country:US
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-12-31
2019-09-29
0000200406
jnj:CONCERTAMethylphenidateMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-07-02
2018-09-30
0000200406
country:US
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-12-31
2019-09-29
0000200406
jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-12-31
2019-09-29
0000200406
jnj:OTCMember
us-gaap:NonUsMember
jnj:ConsumerMember
2018-01-01
2018-09-30
0000200406
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-12-31
2019-09-29
0000200406
jnj:MedicalDevicesMember
jnj:VisionMember
2019-07-01
2019-09-29
0000200406
jnj:BeautyMember
us-gaap:NonUsMember
jnj:ConsumerMember
2018-07-02
2018-09-30
0000200406
jnj:OTCMember
country:US
jnj:ConsumerMember
2018-12-31
2019-09-29
0000200406
country:US
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-01-01
2018-09-30
0000200406
jnj:CONCERTAMethylphenidateMember
country:US
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2019-07-01
2019-09-29
0000200406
jnj:ZYTIGAMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-07-02
2018-09-30
0000200406
jnj:RemicadeMember
jnj:UNITEDSTATESExportsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-12-31
2019-09-29
0000200406
country:US
jnj:MedicalDevicesMember
jnj:VisionMember
2018-07-02
2018-09-30
0000200406
jnj:PharmaceuticalMember
2018-01-01
2018-09-30
0000200406
jnj:INVOKANAINVOKAMETMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-12-31
2019-09-29
0000200406
jnj:TRACLEERMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-01-01
2018-09-30
0000200406
jnj:StelaraMember
country:US
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-01-01
2018-09-30
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-12-31
2019-09-29
0000200406
jnj:SURGICALMember
country:US
jnj:MedicalDevicesMember
jnj:VisionMember
2018-07-02
2018-09-30
0000200406
jnj:BeautyMember
us-gaap:NonUsMember
jnj:ConsumerMember
2019-07-01
2019-09-29
0000200406
jnj:KNEESMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-12-31
2019-09-29
0000200406
jnj:OtherOncologyMember
country:US
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-01-01
2018-09-30
0000200406
jnj:OtherMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-12-31
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:ConsumerMember
2018-07-02
2018-09-30
0000200406
jnj:CONTACTLENSESOTHERMember
jnj:MedicalDevicesMember
jnj:VisionMember
2019-07-01
2019-09-29
0000200406
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-01-01
2018-09-30
0000200406
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-01-01
2018-09-30
0000200406
jnj:GENERALMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2019-07-01
2019-09-29
0000200406
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-12-31
2019-09-29
0000200406
country:US
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-12-31
2019-09-29
0000200406
jnj:ZYTIGAMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2019-07-01
2019-09-29
0000200406
country:US
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-12-31
2019-09-29
0000200406
country:US
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-12-31
2019-09-29
0000200406
jnj:UPTRAVIMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-01-01
2018-09-30
0000200406
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-01-01
2018-09-30
0000200406
jnj:XareltoMember
country:US
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-12-31
2019-09-29
0000200406
jnj:StelaraMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-01-01
2018-09-30
0000200406
jnj:TremfyaMember
country:US
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-12-31
2019-09-29
0000200406
jnj:BabyCareMember
us-gaap:NonUsMember
jnj:ConsumerMember
2018-07-02
2018-09-30
0000200406
jnj:DARZALEXMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-07-02
2018-09-30
0000200406
jnj:DARZALEXMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2019-07-01
2019-09-29
0000200406
jnj:TRAUMAMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-12-31
2019-09-29
0000200406
jnj:INVOKANAINVOKAMETMember
country:US
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-12-31
2019-09-29
0000200406
jnj:SPECIALTYMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-12-31
2019-09-29
0000200406
jnj:HIPSMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2019-07-01
2019-09-29
0000200406
jnj:CONCERTAMethylphenidateMember
country:US
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-12-31
2019-09-29
0000200406
jnj:MedicalDevicesMember
jnj:InterventionalSolutionsMember
2018-12-31
2019-09-29
0000200406
jnj:BabyCareMember
country:US
jnj:ConsumerMember
2018-12-31
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:VisionMember
2018-01-01
2018-09-30
0000200406
jnj:SPINEOTHERMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-07-02
2018-09-30
0000200406
jnj:RISPERDALCONSTAMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2019-07-01
2019-09-29
0000200406
jnj:CONTACTLENSESOTHERMember
country:US
jnj:MedicalDevicesMember
jnj:VisionMember
2019-07-01
2019-09-29
0000200406
jnj:CONTACTLENSESOTHERMember
jnj:MedicalDevicesMember
jnj:VisionMember
2018-12-31
2019-09-29
0000200406
jnj:StelaraMember
country:US
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2019-07-01
2019-09-29
0000200406
jnj:KNEESMember
country:US
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-12-31
2019-09-29
0000200406
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-12-31
2019-09-29
0000200406
jnj:OPSUMITMember
country:US
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-12-31
2019-09-29
0000200406
jnj:PROCRITEPREXMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-12-31
2019-09-29
0000200406
jnj:UPTRAVIMember
country:US
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-12-31
2019-09-29
0000200406
country:US
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-07-02
2018-09-30
0000200406
jnj:VELCADEMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-12-31
2019-09-29
0000200406
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-01-01
2018-09-30
0000200406
jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-12-31
2019-09-29
0000200406
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-12-31
2019-09-29
0000200406
country:US
jnj:MedicalDevicesMember
2019-07-01
2019-09-29
0000200406
jnj:EDURANTrilpivirineMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2019-07-01
2019-09-29
0000200406
jnj:MedicalDevicesMember
jnj:SurgeryMember
2019-07-01
2019-09-29
0000200406
jnj:TRAUMAMember
country:US
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-12-31
2019-09-29
0000200406
jnj:VELCADEMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2019-07-01
2019-09-29
0000200406
jnj:OtherInfectiousDiseasesMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-12-31
2019-09-29
0000200406
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-01-01
2018-09-30
0000200406
jnj:TremfyaMember
country:US
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2019-07-01
2019-09-29
0000200406
jnj:OralCareMember
us-gaap:NonUsMember
jnj:ConsumerMember
2018-12-31
2019-09-29
0000200406
jnj:PharmaceuticalMember
2019-07-01
2019-09-29
0000200406
jnj:OtherMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2019-07-01
2019-09-29
0000200406
us-gaap:NonUsMember
2018-12-31
2019-09-29
0000200406
jnj:VELCADEMember
country:US
jnj:PharmaceuticalMember
jnj:OncologyMember
2019-07-01
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-01-01
2018-09-30
0000200406
jnj:RISPERDALCONSTAMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-01-01
2018-09-30
0000200406
jnj:RISPERDALCONSTAMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-12-31
2019-09-29
0000200406
jnj:CONCERTAMethylphenidateMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2019-07-01
2019-09-29
0000200406
jnj:MedicalDevicesMember
jnj:DiabetesCareMember
2018-07-02
2018-09-30
0000200406
jnj:SPECIALTYMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-01-01
2018-09-30
0000200406
jnj:StelaraMember
country:US
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-07-02
2018-09-30
0000200406
jnj:ZYTIGAMember
country:US
jnj:PharmaceuticalMember
jnj:OncologyMember
2019-07-01
2019-09-29
0000200406
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2019-07-01
2019-09-29
0000200406
jnj:BabyCareMember
jnj:ConsumerMember
2018-01-01
2018-09-30
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-01-01
2018-09-30
0000200406
jnj:PROCRITEPREXMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-01-01
2018-09-30
0000200406
jnj:OralCareMember
jnj:ConsumerMember
2018-12-31
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-12-31
2019-09-29
0000200406
country:US
jnj:MedicalDevicesMember
jnj:DiabetesCareMember
2018-07-02
2018-09-30
0000200406
jnj:KNEESMember
country:US
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-07-02
2018-09-30
0000200406
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2019-07-01
2019-09-29
0000200406
jnj:SURGICALMember
jnj:MedicalDevicesMember
jnj:VisionMember
2019-07-01
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-01-01
2018-09-30
0000200406
jnj:ADVANCEDMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2019-07-01
2019-09-29
0000200406
country:US
jnj:ConsumerMember
2018-12-31
2019-09-29
0000200406
jnj:ADVANCEDMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-01-01
2018-09-30
0000200406
jnj:GENERALMember
country:US
jnj:MedicalDevicesMember
jnj:SurgeryMember
2019-07-01
2019-09-29
0000200406
country:US
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-12-31
2019-09-29
0000200406
jnj:OtherMember
country:US
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2019-07-01
2019-09-29
0000200406
jnj:MedicalDevicesMember
jnj:VisionMember
2018-07-02
2018-09-30
0000200406
jnj:ADVANCEDMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2019-07-01
2019-09-29
0000200406
jnj:RemicadeMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-12-31
2019-09-29
0000200406
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-07-02
2018-09-30
0000200406
jnj:OTCMember
us-gaap:NonUsMember
jnj:ConsumerMember
2019-07-01
2019-09-29
0000200406
jnj:HIPSMember
country:US
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-12-31
2019-09-29
0000200406
jnj:KNEESMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2019-07-01
2019-09-29
0000200406
jnj:RemicadeMember
jnj:UNITEDSTATESExportsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-01-01
2018-09-30
0000200406
jnj:EDURANTrilpivirineMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2019-07-01
2019-09-29
0000200406
jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-12-31
2019-09-29
0000200406
jnj:XareltoMember
country:US
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-07-02
2018-09-30
0000200406
jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember
country:US
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-12-31
2019-09-29
0000200406
jnj:KNEESMember
country:US
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2019-07-01
2019-09-29
0000200406
jnj:OtherInfectiousDiseasesMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2019-07-01
2019-09-29
0000200406
jnj:PROCRITEPREXMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-01-01
2018-09-30
0000200406
jnj:TremfyaMember
country:US
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-01-01
2018-09-30
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-12-31
2019-09-29
0000200406
jnj:RISPERDALCONSTAMember
country:US
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-07-02
2018-09-30
0000200406
country:US
jnj:PharmaceuticalMember
2018-01-01
2018-09-30
0000200406
jnj:UPTRAVIMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-12-31
2019-09-29
0000200406
jnj:DARZALEXMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-07-02
2018-09-30
0000200406
jnj:WoundCareandOtherMember
jnj:ConsumerMember
2018-01-01
2018-09-30
0000200406
jnj:OtherMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2019-07-01
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-01-01
2018-09-30
0000200406
jnj:WoundCareandOtherMember
jnj:ConsumerMember
2019-07-01
2019-09-29
0000200406
country:US
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-12-31
2019-09-29
0000200406
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-07-02
2018-09-30
0000200406
jnj:OralCareMember
us-gaap:NonUsMember
jnj:ConsumerMember
2019-07-01
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-07-02
2018-09-30
0000200406
jnj:OtherInfectiousDiseasesMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2019-07-01
2019-09-29
0000200406
jnj:SPECIALTYMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-07-02
2018-09-30
0000200406
jnj:SimponiSimponiAriaMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-12-31
2019-09-29
0000200406
jnj:StelaraMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-12-31
2019-09-29
0000200406
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-12-31
2019-09-29
0000200406
jnj:OtherImmunologyMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-12-31
2019-09-29
0000200406
jnj:OPSUMITMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-01-01
2018-09-30
0000200406
jnj:OtherInfectiousDiseasesMember
country:US
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-01-01
2018-09-30
0000200406
jnj:OtherMember
country:US
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-12-31
2019-09-29
0000200406
country:US
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-07-02
2018-09-30
0000200406
jnj:OTHERNEUROSCIENCEMember
country:US
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2019-07-01
2019-09-29
0000200406
jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember
country:US
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-07-02
2018-09-30
0000200406
jnj:OPSUMITMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-01-01
2018-09-30
0000200406
country:US
jnj:MedicalDevicesMember
2018-07-02
2018-09-30
0000200406
jnj:MedicalDevicesMember
jnj:InterventionalSolutionsMember
2018-07-02
2018-09-30
0000200406
jnj:BeautyMember
us-gaap:NonUsMember
jnj:ConsumerMember
2018-12-31
2019-09-29
0000200406
jnj:ADVANCEDMember
country:US
jnj:MedicalDevicesMember
jnj:SurgeryMember
2019-07-01
2019-09-29
0000200406
jnj:BeautyMember
jnj:ConsumerMember
2019-07-01
2019-09-29
0000200406
jnj:TRACLEERMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-07-02
2018-09-30
0000200406
jnj:ADVANCEDMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-07-02
2018-09-30
0000200406
jnj:SURGICALMember
jnj:MedicalDevicesMember
jnj:VisionMember
2018-01-01
2018-09-30
0000200406
jnj:XareltoMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-01-01
2018-09-30
0000200406
jnj:SPINEOTHERMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2019-07-01
2019-09-29
0000200406
country:US
jnj:MedicalDevicesMember
jnj:InterventionalSolutionsMember
2018-12-31
2019-09-29
0000200406
jnj:GENERALMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-07-02
2018-09-30
0000200406
jnj:CONTACTLENSESOTHERMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:VisionMember
2018-12-31
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2019-07-01
2019-09-29
0000200406
jnj:SPECIALTYMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-12-31
2019-09-29
0000200406
jnj:EDURANTrilpivirineMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-01-01
2018-09-30
0000200406
jnj:StelaraMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2019-07-01
2019-09-29
0000200406
jnj:ADVANCEDMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-07-02
2018-09-30
0000200406
jnj:OTCMember
us-gaap:NonUsMember
jnj:ConsumerMember
2018-07-02
2018-09-30
0000200406
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:VisionMember
2019-07-01
2019-09-29
0000200406
jnj:SURGICALMember
country:US
jnj:MedicalDevicesMember
jnj:VisionMember
2019-07-01
2019-09-29
0000200406
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-12-31
2019-09-29
0000200406
jnj:OPSUMITMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-12-31
2019-09-29
0000200406
jnj:WoundCareandOtherMember
jnj:ConsumerMember
2018-12-31
2019-09-29
0000200406
country:US
jnj:PharmaceuticalMember
2019-07-01
2019-09-29
0000200406
jnj:SURGICALMember
jnj:MedicalDevicesMember
jnj:VisionMember
2018-07-02
2018-09-30
0000200406
jnj:IMBRUVICAMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-12-31
2019-09-29
0000200406
jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember
country:US
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2019-07-01
2019-09-29
0000200406
jnj:MedicalDevicesMember
2019-07-01
2019-09-29
0000200406
jnj:GENERALMember
country:US
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-01-01
2018-09-30
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-07-02
2018-09-30
0000200406
jnj:OtherMember
country:US
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-07-02
2018-09-30
0000200406
jnj:ConsumerMember
2018-07-02
2018-09-30
0000200406
jnj:OTCMember
us-gaap:NonUsMember
jnj:ConsumerMember
2018-12-31
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:MedicalDevicesMember
2018-01-01
2018-09-30
0000200406
jnj:SimponiSimponiAriaMember
country:US
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2019-07-01
2019-09-29
0000200406
jnj:OTCMember
jnj:ConsumerMember
2019-07-01
2019-09-29
0000200406
jnj:OTHERNEUROSCIENCEMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-07-02
2018-09-30
0000200406
jnj:PROCRITEPREXMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-12-31
2019-09-29
0000200406
jnj:WomensHealthMember
jnj:ConsumerMember
2018-12-31
2019-09-29
0000200406
country:US
jnj:ConsumerMember
2018-01-01
2018-09-30
0000200406
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2019-07-01
2019-09-29
0000200406
country:US
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-01-01
2018-09-30
0000200406
jnj:DARZALEXMember
country:US
jnj:PharmaceuticalMember
jnj:OncologyMember
2019-07-01
2019-09-29
0000200406
jnj:ZYTIGAMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-12-31
2019-09-29
0000200406
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2019-07-01
2019-09-29
0000200406
jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-07-02
2018-09-30
0000200406
jnj:OtherMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-07-02
2018-09-30
0000200406
jnj:XareltoMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2019-07-01
2019-09-29
0000200406
jnj:BeautyMember
jnj:ConsumerMember
2018-12-31
2019-09-29
0000200406
jnj:TRAUMAMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-12-31
2019-09-29
0000200406
jnj:OtherInfectiousDiseasesMember
country:US
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2019-07-01
2019-09-29
0000200406
jnj:IMBRUVICAMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2019-07-01
2019-09-29
0000200406
jnj:ZYTIGAMember
country:US
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-12-31
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
2019-07-01
2019-09-29
0000200406
jnj:RemicadeMember
country:US
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2019-07-01
2019-09-29
0000200406
jnj:WoundCareandOtherMember
country:US
jnj:ConsumerMember
2018-01-01
2018-09-30
0000200406
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-07-02
2018-09-30
0000200406
jnj:INVOKANAINVOKAMETMember
country:US
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-01-01
2018-09-30
0000200406
jnj:OTHERNEUROSCIENCEMember
country:US
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-01-01
2018-09-30
0000200406
jnj:ADVANCEDMember
country:US
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-12-31
2019-09-29
0000200406
jnj:CONCERTAMethylphenidateMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2019-07-01
2019-09-29
0000200406
country:US
jnj:PharmaceuticalMember
2018-12-31
2019-09-29
0000200406
jnj:XareltoMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-01-01
2018-09-30
0000200406
jnj:MedicalDevicesMember
2018-07-02
2018-09-30
0000200406
jnj:DARZALEXMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2019-07-01
2019-09-29
0000200406
jnj:RemicadeMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-01-01
2018-09-30
0000200406
jnj:SPINEOTHERMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-07-02
2018-09-30
0000200406
jnj:GENERALMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-01-01
2018-09-30
0000200406
jnj:OPSUMITMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2019-07-01
2019-09-29
0000200406
jnj:KNEESMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2019-07-01
2019-09-29
0000200406
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-12-31
2019-09-29
0000200406
country:US
jnj:ConsumerMember
2018-07-02
2018-09-30
0000200406
country:US
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-01-01
2018-09-30
0000200406
jnj:RISPERDALCONSTAMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2019-07-01
2019-09-29
0000200406
jnj:INVOKANAINVOKAMETMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-01-01
2018-09-30
0000200406
jnj:RISPERDALCONSTAMember
country:US
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2019-07-01
2019-09-29
0000200406
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-12-31
2019-09-29
0000200406
jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2019-07-01
2019-09-29
0000200406
jnj:TRAUMAMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-01-01
2018-09-30
0000200406
jnj:DARZALEXMember
country:US
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-12-31
2019-09-29
0000200406
jnj:SURGICALMember
country:US
jnj:MedicalDevicesMember
jnj:VisionMember
2018-01-01
2018-09-30
0000200406
jnj:VELCADEMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2019-07-01
2019-09-29
0000200406
jnj:EDURANTrilpivirineMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-07-02
2018-09-30
0000200406
country:US
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-12-31
2019-09-29
0000200406
jnj:CONCERTAMethylphenidateMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-12-31
2019-09-29
0000200406
jnj:CONTACTLENSESOTHERMember
jnj:MedicalDevicesMember
jnj:VisionMember
2018-07-02
2018-09-30
0000200406
jnj:OTHERNEUROSCIENCEMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-12-31
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:InterventionalSolutionsMember
2019-07-01
2019-09-29
0000200406
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-07-02
2018-09-30
0000200406
jnj:UPTRAVIMember
country:US
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-01-01
2018-09-30
0000200406
jnj:OPSUMITMember
country:US
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-01-01
2018-09-30
0000200406
jnj:GENERALMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-12-31
2019-09-29
0000200406
jnj:XareltoMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-07-02
2018-09-30
0000200406
jnj:BabyCareMember
us-gaap:NonUsMember
jnj:ConsumerMember
2018-12-31
2019-09-29
0000200406
jnj:RemicadeMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-12-31
2019-09-29
0000200406
country:US
jnj:ConsumerMember
2019-07-01
2019-09-29
0000200406
jnj:SPINEOTHERMember
country:US
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-12-31
2019-09-29
0000200406
jnj:TremfyaMember
country:US
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-07-02
2018-09-30
0000200406
jnj:CONTACTLENSESOTHERMember
jnj:MedicalDevicesMember
jnj:VisionMember
2018-01-01
2018-09-30
0000200406
jnj:CONTACTLENSESOTHERMember
country:US
jnj:MedicalDevicesMember
jnj:VisionMember
2018-12-31
2019-09-29
0000200406
jnj:OtherMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2019-07-01
2019-09-29
0000200406
jnj:MedicalDevicesMember
2018-01-01
2018-09-30
0000200406
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:VisionMember
2018-12-31
2019-09-29
0000200406
jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember
country:US
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-12-31
2019-09-29
0000200406
jnj:RemicadeMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-07-02
2018-09-30
0000200406
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2019-07-01
2019-09-29
0000200406
jnj:TRACLEERMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-12-31
2019-09-29
0000200406
jnj:OTCMember
jnj:ConsumerMember
2018-01-01
2018-09-30
0000200406
jnj:XareltoMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-12-31
2019-09-29
0000200406
jnj:RemicadeMember
jnj:UNITEDSTATESExportsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2019-07-01
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-12-31
2019-09-29
0000200406
jnj:HIPSMember
country:US
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2019-07-01
2019-09-29
0000200406
jnj:SimponiSimponiAriaMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2019-07-01
2019-09-29
0000200406
jnj:EDURANTrilpivirineMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-12-31
2019-09-29
0000200406
jnj:WoundCareandOtherMember
country:US
jnj:ConsumerMember
2018-07-02
2018-09-30
0000200406
jnj:TRACLEERMember
country:US
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-12-31
2019-09-29
0000200406
jnj:SPINEOTHERMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2019-07-01
2019-09-29
0000200406
jnj:StelaraMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-12-31
2019-09-29
0000200406
country:US
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2019-07-01
2019-09-29
0000200406
jnj:OTHERNEUROSCIENCEMember
country:US
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-12-31
2019-09-29
0000200406
jnj:OtherMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-07-02
2018-09-30
0000200406
jnj:SURGICALMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:VisionMember
2019-07-01
2019-09-29
0000200406
jnj:SPECIALTYMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2019-07-01
2019-09-29
0000200406
jnj:TremfyaMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2019-07-01
2019-09-29
0000200406
jnj:OTHERNEUROSCIENCEMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2019-07-01
2019-09-29
0000200406
jnj:CONCERTAMethylphenidateMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-12-31
2019-09-29
0000200406
jnj:OtherOncologyMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-12-31
2019-09-29
0000200406
country:US
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-07-02
2018-09-30
0000200406
jnj:RemicadeMember
country:US
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-07-02
2018-09-30
0000200406
jnj:RISPERDALCONSTAMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-01-01
2018-09-30
0000200406
jnj:OtherImmunologyMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-07-02
2018-09-30
0000200406
jnj:XareltoMember
country:US
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2019-07-01
2019-09-29
0000200406
jnj:VELCADEMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-01-01
2018-09-30
0000200406
country:US
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-01-01
2018-09-30
0000200406
jnj:IMBRUVICAMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2019-07-01
2019-09-29
0000200406
country:US
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2019-07-01
2019-09-29
0000200406
jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember
country:US
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2019-07-01
2019-09-29
0000200406
jnj:SPECIALTYMember
country:US
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-01-01
2018-09-30
0000200406
jnj:BabyCareMember
us-gaap:NonUsMember
jnj:ConsumerMember
2018-01-01
2018-09-30
0000200406
jnj:CONCERTAMethylphenidateMember
country:US
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-07-02
2018-09-30
0000200406
country:US
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-07-02
2018-09-30
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2019-07-01
2019-09-29
0000200406
jnj:OtherOncologyMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-12-31
2019-09-29
0000200406
jnj:TRAUMAMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-07-02
2018-09-30
0000200406
jnj:BeautyMember
jnj:ConsumerMember
2018-01-01
2018-09-30
0000200406
jnj:SimponiSimponiAriaMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-12-31
2019-09-29
0000200406
jnj:OPSUMITMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-07-02
2018-09-30
0000200406
jnj:BabyCareMember
jnj:ConsumerMember
2018-12-31
2019-09-29
0000200406
jnj:EDURANTrilpivirineMember
country:US
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2019-07-01
2019-09-29
0000200406
jnj:PROCRITEPREXMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-07-02
2018-09-30
0000200406
country:US
2019-07-01
2019-09-29
0000200406
jnj:XareltoMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-12-31
2019-09-29
0000200406
jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2019-07-01
2019-09-29
0000200406
jnj:OTHERNEUROSCIENCEMember
country:US
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-07-02
2018-09-30
0000200406
jnj:BabyCareMember
country:US
jnj:ConsumerMember
2019-07-01
2019-09-29
0000200406
jnj:TRACLEERMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-12-31
2019-09-29
0000200406
jnj:IMBRUVICAMember
country:US
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-07-02
2018-09-30
0000200406
jnj:OtherInfectiousDiseasesMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-01-01
2018-09-30
0000200406
jnj:SimponiSimponiAriaMember
country:US
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-12-31
2019-09-29
0000200406
jnj:ADVANCEDMember
country:US
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-07-02
2018-09-30
0000200406
jnj:TRAUMAMember
country:US
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-07-02
2018-09-30
0000200406
country:US
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-01-01
2018-09-30
0000200406
jnj:SPINEOTHERMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-12-31
2019-09-29
0000200406
jnj:TremfyaMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2019-07-01
2019-09-29
0000200406
jnj:SURGICALMember
jnj:MedicalDevicesMember
jnj:VisionMember
2018-12-31
2019-09-29
0000200406
jnj:RISPERDALCONSTAMember
country:US
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-01-01
2018-09-30
0000200406
jnj:TRAUMAMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-01-01
2018-09-30
0000200406
jnj:PROCRITEPREXMember
country:US
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-01-01
2018-09-30
0000200406
country:US
jnj:PharmaceuticalMember
jnj:OncologyMember
2019-07-01
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-12-31
2019-09-29
0000200406
jnj:OtherImmunologyMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2019-07-01
2019-09-29
0000200406
jnj:ADVANCEDMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-12-31
2019-09-29
0000200406
jnj:RemicadeMember
jnj:UNITEDSTATESExportsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-07-02
2018-09-30
0000200406
jnj:KNEESMember
country:US
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-01-01
2018-09-30
0000200406
jnj:IMBRUVICAMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-12-31
2019-09-29
0000200406
jnj:INVOKANAINVOKAMETMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-07-02
2018-09-30
0000200406
country:US
jnj:MedicalDevicesMember
2018-01-01
2018-09-30
0000200406
country:US
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2019-07-01
2019-09-29
0000200406
jnj:ZYTIGAMember
country:US
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-07-02
2018-09-30
0000200406
jnj:OtherOncologyMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-01-01
2018-09-30
0000200406
country:US
jnj:MedicalDevicesMember
jnj:InterventionalSolutionsMember
2018-01-01
2018-09-30
0000200406
jnj:OPSUMITMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-12-31
2019-09-29
0000200406
jnj:OralCareMember
us-gaap:NonUsMember
jnj:ConsumerMember
2018-07-02
2018-09-30
0000200406
country:US
2018-07-02
2018-09-30
0000200406
jnj:SPINEOTHERMember
country:US
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-01-01
2018-09-30
0000200406
jnj:OtherMember
country:US
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-12-31
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:MedicalDevicesMember
2019-07-01
2019-09-29
0000200406
jnj:VELCADEMember
country:US
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-12-31
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:InterventionalSolutionsMember
2018-01-01
2018-09-30
0000200406
jnj:OtherOncologyMember
country:US
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-07-02
2018-09-30
0000200406
country:US
jnj:MedicalDevicesMember
jnj:VisionMember
2018-01-01
2018-09-30
0000200406
jnj:OtherMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-01-01
2018-09-30
0000200406
country:US
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-01-01
2018-09-30
0000200406
jnj:INVOKANAINVOKAMETMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-12-31
2019-09-29
0000200406
jnj:TRACLEERMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-01-01
2018-09-30
0000200406
jnj:TremfyaMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-01-01
2018-09-30
0000200406
jnj:SPECIALTYMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2019-07-01
2019-09-29
0000200406
jnj:SPECIALTYMember
country:US
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-12-31
2019-09-29
0000200406
jnj:PharmaceuticalMember
jnj:OncologyMember
2019-07-01
2019-09-29
0000200406
jnj:PROCRITEPREXMember
country:US
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2019-07-01
2019-09-29
0000200406
country:US
jnj:MedicalDevicesMember
jnj:InterventionalSolutionsMember
2018-07-02
2018-09-30
0000200406
jnj:INVOKANAINVOKAMETMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2019-07-01
2019-09-29
0000200406
jnj:TRACLEERMember
country:US
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2019-07-01
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-12-31
2019-09-29
0000200406
jnj:SimponiSimponiAriaMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-01-01
2018-09-30
0000200406
jnj:ConsumerMember
2019-07-01
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-07-02
2018-09-30
0000200406
jnj:WoundCareandOtherMember
country:US
jnj:ConsumerMember
2019-07-01
2019-09-29
0000200406
us-gaap:NonUsMember
2018-07-02
2018-09-30
0000200406
country:US
jnj:MedicalDevicesMember
jnj:VisionMember
2019-07-01
2019-09-29
0000200406
jnj:INVOKANAINVOKAMETMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-01-01
2018-09-30
0000200406
jnj:KNEESMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-12-31
2019-09-29
0000200406
jnj:OtherMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-12-31
2019-09-29
0000200406
jnj:VELCADEMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-01-01
2018-09-30
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-01-01
2018-09-30
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-12-31
2019-09-29
0000200406
jnj:UPTRAVIMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-07-02
2018-09-30
0000200406
jnj:WomensHealthMember
us-gaap:NonUsMember
jnj:ConsumerMember
2019-07-01
2019-09-29
0000200406
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2019-07-01
2019-09-29
0000200406
jnj:UPTRAVIMember
country:US
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2019-07-01
2019-09-29
0000200406
jnj:SURGICALMember
country:US
jnj:MedicalDevicesMember
jnj:VisionMember
2018-12-31
2019-09-29
0000200406
jnj:OralCareMember
country:US
jnj:ConsumerMember
2018-07-02
2018-09-30
0000200406
country:US
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2019-07-01
2019-09-29
0000200406
jnj:WomensHealthMember
country:US
jnj:ConsumerMember
2019-07-01
2019-09-29
0000200406
jnj:INVOKANAINVOKAMETMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2019-07-01
2019-09-29
0000200406
jnj:PROCRITEPREXMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-07-02
2018-09-30
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2019-07-01
2019-09-29
0000200406
jnj:OralCareMember
country:US
jnj:ConsumerMember
2018-01-01
2018-09-30
0000200406
jnj:DARZALEXMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-01-01
2018-09-30
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
2018-07-02
2018-09-30
0000200406
jnj:BeautyMember
country:US
jnj:ConsumerMember
2019-07-01
2019-09-29
0000200406
jnj:CONTACTLENSESOTHERMember
country:US
jnj:MedicalDevicesMember
jnj:VisionMember
2018-01-01
2018-09-30
0000200406
jnj:OTCMember
jnj:ConsumerMember
2018-12-31
2019-09-29
0000200406
jnj:SimponiSimponiAriaMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-07-02
2018-09-30
0000200406
country:US
jnj:MedicalDevicesMember
jnj:InterventionalSolutionsMember
2019-07-01
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2019-07-01
2019-09-29
0000200406
jnj:KNEESMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-01-01
2018-09-30
0000200406
jnj:BeautyMember
country:US
jnj:ConsumerMember
2018-07-02
2018-09-30
0000200406
jnj:OTCMember
country:US
jnj:ConsumerMember
2019-07-01
2019-09-29
0000200406
jnj:WoundCareandOtherMember
us-gaap:NonUsMember
jnj:ConsumerMember
2018-01-01
2018-09-30
0000200406
jnj:UPTRAVIMember
country:US
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-07-02
2018-09-30
0000200406
jnj:OralCareMember
jnj:ConsumerMember
2019-07-01
2019-09-29
0000200406
jnj:HIPSMember
country:US
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-07-02
2018-09-30
0000200406
jnj:HIPSMember
country:US
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-01-01
2018-09-30
0000200406
jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2019-07-01
2019-09-29
0000200406
jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-07-02
2018-09-30
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
2018-01-01
2018-09-30
0000200406
jnj:TremfyaMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-01-01
2018-09-30
0000200406
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:DiabetesCareMember
2018-01-01
2018-09-30
0000200406
jnj:OtherInfectiousDiseasesMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-07-02
2018-09-30
0000200406
jnj:TRAUMAMember
country:US
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2019-07-01
2019-09-29
0000200406
jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember
country:US
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-01-01
2018-09-30
0000200406
jnj:TRACLEERMember
country:US
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-07-02
2018-09-30
0000200406
jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-07-02
2018-09-30
0000200406
jnj:RISPERDALCONSTAMember
country:US
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-12-31
2019-09-29
0000200406
country:US
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-12-31
2019-09-29
0000200406
jnj:OtherImmunologyMember
country:US
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2019-07-01
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:MedicalDevicesMember
2018-12-31
2019-09-29
0000200406
jnj:TRAUMAMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2019-07-01
2019-09-29
0000200406
jnj:BabyCareMember
country:US
jnj:ConsumerMember
2018-01-01
2018-09-30
0000200406
jnj:RemicadeMember
country:US
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-12-31
2019-09-29
0000200406
jnj:OtherMember
country:US
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2019-07-01
2019-09-29
0000200406
jnj:OtherOncologyMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-07-02
2018-09-30
0000200406
country:US
jnj:MedicalDevicesMember
jnj:VisionMember
2018-12-31
2019-09-29
0000200406
jnj:DARZALEXMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-01-01
2018-09-30
0000200406
jnj:EDURANTrilpivirineMember
country:US
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-01-01
2018-09-30
0000200406
jnj:UPTRAVIMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2019-07-01
2019-09-29
0000200406
country:US
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2019-07-01
2019-09-29
0000200406
jnj:WoundCareandOtherMember
us-gaap:NonUsMember
jnj:ConsumerMember
2019-07-01
2019-09-29
0000200406
jnj:OralCareMember
jnj:ConsumerMember
2018-07-02
2018-09-30
0000200406
jnj:WomensHealthMember
country:US
jnj:ConsumerMember
2018-12-31
2019-09-29
0000200406
jnj:RISPERDALCONSTAMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-07-02
2018-09-30
0000200406
jnj:OtherOncologyMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2019-07-01
2019-09-29
0000200406
jnj:VELCADEMember
country:US
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-01-01
2018-09-30
0000200406
jnj:DARZALEXMember
country:US
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-01-01
2018-09-30
0000200406
jnj:SPINEOTHERMember
country:US
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2019-07-01
2019-09-29
0000200406
jnj:WomensHealthMember
jnj:ConsumerMember
2019-07-01
2019-09-29
0000200406
jnj:TremfyaMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-12-31
2019-09-29
0000200406
jnj:MedicalDevicesMember
jnj:DiabetesCareMember
2019-07-01
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:InterventionalSolutionsMember
2018-07-02
2018-09-30
0000200406
jnj:GENERALMember
country:US
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-07-02
2018-09-30
0000200406
jnj:IMBRUVICAMember
country:US
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-01-01
2018-09-30
0000200406
jnj:HIPSMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2019-07-01
2019-09-29
0000200406
jnj:TremfyaMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-12-31
2019-09-29
0000200406
jnj:OtherImmunologyMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-07-02
2018-09-30
0000200406
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-01-01
2018-09-30
0000200406
jnj:ConsumerMember
2018-01-01
2018-09-30
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-07-02
2018-09-30
0000200406
jnj:RemicadeMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-01-01
2018-09-30
0000200406
jnj:MedicalDevicesMember
jnj:DiabetesCareMember
2018-12-31
2019-09-29
0000200406
jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-01-01
2018-09-30
0000200406
jnj:EDURANTrilpivirineMember
country:US
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-12-31
2019-09-29
0000200406
country:US
jnj:MedicalDevicesMember
jnj:DiabetesCareMember
2018-12-31
2019-09-29
0000200406
jnj:OtherInfectiousDiseasesMember
country:US
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-12-31
2019-09-29
0000200406
jnj:VELCADEMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-07-02
2018-09-30
0000200406
country:US
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-07-02
2018-09-30
0000200406
jnj:SimponiSimponiAriaMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-01-01
2018-09-30
0000200406
jnj:UPTRAVIMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2019-07-01
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2019-07-01
2019-09-29
0000200406
jnj:OtherOncologyMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2019-07-01
2019-09-29
0000200406
us-gaap:NonUsMember
2019-07-01
2019-09-29
0000200406
jnj:EDURANTrilpivirineMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-12-31
2019-09-29
0000200406
jnj:ZYTIGAMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-01-01
2018-09-30
0000200406
jnj:OtherMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-01-01
2018-09-30
0000200406
jnj:OPSUMITMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2019-07-01
2019-09-29
0000200406
jnj:HIPSMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-12-31
2019-09-29
0000200406
jnj:ZYTIGAMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-12-31
2019-09-29
0000200406
jnj:GENERALMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2019-07-01
2019-09-29
0000200406
jnj:INVOKANAINVOKAMETMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-07-02
2018-09-30
0000200406
jnj:WomensHealthMember
country:US
jnj:ConsumerMember
2018-01-01
2018-09-30
0000200406
jnj:HIPSMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-07-02
2018-09-30
0000200406
jnj:WomensHealthMember
country:US
jnj:ConsumerMember
2018-07-02
2018-09-30
0000200406
jnj:OtherMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-07-02
2018-09-30
0000200406
jnj:TRAUMAMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2019-07-01
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:ConsumerMember
2019-07-01
2019-09-29
0000200406
jnj:OtherMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-12-31
2019-09-29
0000200406
country:US
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-01-01
2018-09-30
0000200406
jnj:BeautyMember
us-gaap:NonUsMember
jnj:ConsumerMember
2018-01-01
2018-09-30
0000200406
jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-01-01
2018-09-30
0000200406
jnj:MedicalDevicesMember
jnj:VisionMember
2018-12-31
2019-09-29
0000200406
jnj:UPTRAVIMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-12-31
2019-09-29
0000200406
jnj:RemicadeMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-07-02
2018-09-30
0000200406
jnj:HIPSMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-01-01
2018-09-30
0000200406
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2019-07-01
2019-09-29
0000200406
jnj:WoundCareandOtherMember
us-gaap:NonUsMember
jnj:ConsumerMember
2018-07-02
2018-09-30
0000200406
jnj:INVOKANAINVOKAMETMember
country:US
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-07-02
2018-09-30
0000200406
jnj:CONTACTLENSESOTHERMember
country:US
jnj:MedicalDevicesMember
jnj:VisionMember
2018-07-02
2018-09-30
0000200406
jnj:VELCADEMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-07-02
2018-09-30
0000200406
jnj:WomensHealthMember
us-gaap:NonUsMember
jnj:ConsumerMember
2018-12-31
2019-09-29
0000200406
jnj:RemicadeMember
country:US
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-01-01
2018-09-30
0000200406
jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2019-07-01
2019-09-29
0000200406
country:US
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-07-02
2018-09-30
0000200406
jnj:ZYTIGAMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-01-01
2018-09-30
0000200406
jnj:MedicalDevicesMember
jnj:VisionMember
2018-01-01
2018-09-30
0000200406
jnj:OralCareMember
us-gaap:NonUsMember
jnj:ConsumerMember
2018-01-01
2018-09-30
0000200406
jnj:SimponiSimponiAriaMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-07-02
2018-09-30
0000200406
jnj:DARZALEXMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-12-31
2019-09-29
0000200406
jnj:OtherInfectiousDiseasesMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-12-31
2019-09-29
0000200406
country:US
jnj:MedicalDevicesMember
jnj:DiabetesCareMember
2019-07-01
2019-09-29
0000200406
jnj:TRACLEERMember
country:US
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-01-01
2018-09-30
0000200406
jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-01-01
2018-09-30
0000200406
jnj:OtherOncologyMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-07-02
2018-09-30
0000200406
jnj:SPECIALTYMember
country:US
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-07-02
2018-09-30
0000200406
country:US
2018-12-31
2019-09-29
0000200406
jnj:TRACLEERMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2019-07-01
2019-09-29
0000200406
jnj:CONCERTAMethylphenidateMember
country:US
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-01-01
2018-09-30
0000200406
jnj:VELCADEMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-12-31
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:VisionMember
2018-07-02
2018-09-30
0000200406
jnj:WomensHealthMember
jnj:ConsumerMember
2018-01-01
2018-09-30
0000200406
jnj:XareltoMember
country:US
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-01-01
2018-09-30
0000200406
jnj:OTCMember
country:US
jnj:ConsumerMember
2018-07-02
2018-09-30
0000200406
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:InterventionalSolutionsMember
2018-12-31
2019-09-29
0000200406
jnj:EDURANTrilpivirineMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-01-01
2018-09-30
0000200406
jnj:OralCareMember
country:US
jnj:ConsumerMember
2018-12-31
2019-09-29
0000200406
jnj:IMBRUVICAMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-07-02
2018-09-30
0000200406
jnj:OtherMember
country:US
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-07-02
2018-09-30
0000200406
jnj:StelaraMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2019-07-01
2019-09-29
0000200406
jnj:DARZALEXMember
country:US
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-07-02
2018-09-30
0000200406
jnj:OtherInfectiousDiseasesMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-01-01
2018-09-30
0000200406
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-01-01
2018-09-30
0000200406
jnj:HIPSMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-07-02
2018-09-30
0000200406
jnj:OPSUMITMember
country:US
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2019-07-01
2019-09-29
0000200406
jnj:MedicalDevicesMember
jnj:DiabetesCareMember
2018-01-01
2018-09-30
0000200406
jnj:PROCRITEPREXMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2019-07-01
2019-09-29
0000200406
jnj:HIPSMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-12-31
2019-09-29
0000200406
jnj:RemicadeMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2019-07-01
2019-09-29
0000200406
jnj:ZYTIGAMember
country:US
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-01-01
2018-09-30
0000200406
jnj:WomensHealthMember
jnj:ConsumerMember
2018-07-02
2018-09-30
0000200406
jnj:WomensHealthMember
us-gaap:NonUsMember
jnj:ConsumerMember
2018-01-01
2018-09-30
0000200406
jnj:StelaraMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-07-02
2018-09-30
0000200406
country:US
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-07-02
2018-09-30
0000200406
jnj:RISPERDALCONSTAMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-12-31
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-01-01
2018-09-30
0000200406
jnj:CONTACTLENSESOTHERMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:VisionMember
2018-01-01
2018-09-30
0000200406
jnj:OtherInfectiousDiseasesMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-07-02
2018-09-30
0000200406
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-07-02
2018-09-30
0000200406
jnj:OtherMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-07-02
2018-09-30
0000200406
jnj:IMBRUVICAMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-07-02
2018-09-30
0000200406
jnj:VELCADEMember
country:US
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-07-02
2018-09-30
0000200406
jnj:OPSUMITMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-07-02
2018-09-30
0000200406
jnj:BabyCareMember
country:US
jnj:ConsumerMember
2018-07-02
2018-09-30
0000200406
jnj:PharmaceuticalMember
2018-07-02
2018-09-30
0000200406
jnj:OTCMember
country:US
jnj:ConsumerMember
2018-01-01
2018-09-30
0000200406
jnj:EDURANTrilpivirineMember
country:US
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-07-02
2018-09-30
0000200406
country:US
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2019-07-01
2019-09-29
0000200406
jnj:BeautyMember
jnj:ConsumerMember
2018-07-02
2018-09-30
0000200406
jnj:WomensHealthMember
us-gaap:NonUsMember
jnj:ConsumerMember
2018-07-02
2018-09-30
0000200406
jnj:KNEESMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-07-02
2018-09-30
0000200406
country:US
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-01-01
2018-09-30
0000200406
jnj:TRAUMAMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-07-02
2018-09-30
0000200406
jnj:TRACLEERMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-07-02
2018-09-30
0000200406
jnj:MedicalDevicesMember
jnj:InterventionalSolutionsMember
2018-01-01
2018-09-30
0000200406
jnj:TremfyaMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-07-02
2018-09-30
0000200406
jnj:EDURANTrilpivirineMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-07-02
2018-09-30
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-07-02
2018-09-30
0000200406
jnj:OtherMember
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-01-01
2018-09-30
0000200406
jnj:BabyCareMember
jnj:ConsumerMember
2019-07-01
2019-09-29
0000200406
jnj:UPTRAVIMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-07-02
2018-09-30
0000200406
jnj:BeautyMember
country:US
jnj:ConsumerMember
2018-01-01
2018-09-30
0000200406
jnj:CONTACTLENSESOTHERMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:VisionMember
2018-07-02
2018-09-30
0000200406
jnj:CONCERTAMethylphenidateMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-01-01
2018-09-30
0000200406
jnj:WoundCareandOtherMember
jnj:ConsumerMember
2018-07-02
2018-09-30
0000200406
jnj:ADVANCEDMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-01-01
2018-09-30
0000200406
jnj:CONCERTAMethylphenidateMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-01-01
2018-09-30
0000200406
jnj:SPECIALTYMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-07-02
2018-09-30
0000200406
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:DiabetesCareMember
2018-07-02
2018-09-30
0000200406
jnj:OtherMember
country:US
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-01-01
2018-09-30
0000200406
jnj:OralCareMember
jnj:ConsumerMember
2018-01-01
2018-09-30
0000200406
jnj:GENERALMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-01-01
2018-09-30
0000200406
us-gaap:NonUsMember
2018-01-01
2018-09-30
0000200406
jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember
jnj:PharmaceuticalMember
jnj:InfectiousDiseasesMember
2018-01-01
2018-09-30
0000200406
jnj:OTHERNEUROSCIENCEMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-01-01
2018-09-30
0000200406
jnj:ZYTIGAMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-07-02
2018-09-30
0000200406
jnj:GENERALMember
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-07-02
2018-09-30
0000200406
jnj:KNEESMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-01-01
2018-09-30
0000200406
country:US
2018-01-01
2018-09-30
0000200406
country:US
jnj:PharmaceuticalMember
2018-07-02
2018-09-30
0000200406
jnj:CONCERTAMethylphenidateMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-07-02
2018-09-30
0000200406
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-01-01
2018-09-30
0000200406
jnj:OtherImmunologyMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-01-01
2018-09-30
0000200406
jnj:StelaraMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-07-02
2018-09-30
0000200406
jnj:OtherOncologyMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:OncologyMember
2018-01-01
2018-09-30
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
2018-12-31
2019-09-29
0000200406
jnj:PROCRITEPREXMember
country:US
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-12-31
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-07-02
2018-09-30
0000200406
jnj:OTHERNEUROSCIENCEMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-07-02
2018-09-30
0000200406
jnj:PROCRITEPREXMember
country:US
jnj:PharmaceuticalMember
jnj:CardiovascularMetabolismOtherMember
2018-07-02
2018-09-30
0000200406
jnj:SPINEOTHERMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-01-01
2018-09-30
0000200406
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-07-02
2018-09-30
0000200406
jnj:SimponiSimponiAriaMember
country:US
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-01-01
2018-09-30
0000200406
jnj:OtherImmunologyMember
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-01-01
2018-09-30
0000200406
jnj:OtherMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-01-01
2018-09-30
0000200406
jnj:RISPERDALCONSTAMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-07-02
2018-09-30
0000200406
us-gaap:NonUsMember
jnj:MedicalDevicesMember
2018-07-02
2018-09-30
0000200406
jnj:OTCMember
jnj:ConsumerMember
2018-07-02
2018-09-30
0000200406
jnj:OTHERNEUROSCIENCEMember
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:NeuroscienceMember
2018-01-01
2018-09-30
0000200406
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:DiabetesCareMember
2019-07-01
2019-09-29
0000200406
us-gaap:NonUsMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-01-01
2018-09-30
0000200406
jnj:ADVANCEDMember
country:US
jnj:MedicalDevicesMember
jnj:SurgeryMember
2018-01-01
2018-09-30
0000200406
jnj:OtherImmunologyMember
country:US
jnj:PharmaceuticalMember
jnj:ImmunologyMember
2018-01-01
2018-09-30
0000200406
jnj:UPTRAVIMember
jnj:PharmaceuticalMember
jnj:PulmonaryHypertensionMember
2018-01-01
2018-09-30
0000200406
jnj:KNEESMember
us-gaap:NonUsMember
jnj:MedicalDevicesMember
jnj:OrthopaedicsMember
2018-07-02
2018-09-30
0000200406
jnj:WesternHemisphereExcludingUSMember
2018-12-31
2019-09-29
0000200406
jnj:WesternHemisphereExcludingUSMember
2018-07-02
2018-09-30
0000200406
jnj:AsiaPacificAfricaMember
2018-12-31
2019-09-29
0000200406
jnj:AsiaPacificAfricaMember
2019-07-01
2019-09-29
0000200406
srt:EuropeMember
2018-07-02
2018-09-30
0000200406
srt:EuropeMember
2018-12-31
2019-09-29
0000200406
jnj:AsiaPacificAfricaMember
2018-07-02
2018-09-30
0000200406
jnj:WesternHemisphereExcludingUSMember
2019-07-01
2019-09-29
0000200406
srt:EuropeMember
2019-07-01
2019-09-29
0000200406
jnj:AsiaPacificAfricaMember
2018-01-01
2018-09-30
0000200406
jnj:WesternHemisphereExcludingUSMember
2018-01-01
2018-09-30
0000200406
srt:EuropeMember
2018-01-01
2018-09-30
0000200406
jnj:XO1Member
jnj:PharmaceuticalMember
2018-07-02
2018-09-30
0000200406
jnj:CizHoldingsCo.Ltd.Member
jnj:ConsumerMember
2018-12-31
2019-09-29
0000200406
jnj:ActelionMember
jnj:PharmaceuticalMember
2018-12-31
2019-09-29
0000200406
jnj:ActelionMember
jnj:PharmaceuticalMember
2018-01-01
2018-09-30
0000200406
us-gaap:OperatingSegmentsMember
jnj:ADVANCEDMember
jnj:MedicalDevicesMember
2018-12-31
2019-09-29
0000200406
jnj:XO1Member
jnj:PharmaceuticalMember
2018-01-01
2018-09-30
0000200406
jnj:AurisHealthMember
2019-04-01
0000200406
srt:MaximumMember
jnj:AurisHealthMember
2019-04-01
0000200406
jnj:CizHoldingsCo.Ltd.Member
2018-10-23
2018-10-23
0000200406
jnj:CizHoldingsCo.Ltd.Member
2019-01-17
0000200406
us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember
jnj:AdvancedSterilizationProductsMember
2019-04-01
0000200406
jnj:CizHoldingsCo.Ltd.Member
2019-09-29
0000200406
jnj:CizHoldingsCo.Ltd.Member
2019-01-16
0000200406
jnj:AdvancedSterilizationProductsMember
2019-07-01
2019-09-29
0000200406
jnj:AurisHealthMember
2019-04-01
2019-06-30
0000200406
srt:MinimumMember
jnj:AurisHealthMember
2019-04-01
0000200406
jnj:CizHoldingsCo.Ltd.Member
2018-10-22
0000200406
jnj:CizHoldingsCo.Ltd.Member
2018-12-31
2019-03-31
0000200406
jnj:BabyPowderMember
us-gaap:JudicialRulingMember
us-gaap:DamagesFromProductDefectsMember
2018-12-31
2019-09-29
0000200406
jnj:TalcMember
2019-09-29
0000200406
us-gaap:JudicialRulingMember
us-gaap:SubsequentEventMember
2019-10-01
2019-10-31
0000200406
jnj:PhysiomeshMember
2019-09-29
0000200406
jnj:PelvicMeshesMember
2019-09-29
0000200406
jnj:AsrMember
2019-09-29
0000200406
jnj:XareltoMember
2019-09-29
0000200406
jnj:OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember
us-gaap:JudicialRulingMember
2018-12-31
2019-09-29
0000200406
jnj:DePuyASRU.S.Member
us-gaap:SettledLitigationMember
2019-09-29
0000200406
jnj:RisperdalMember
2019-09-29
0000200406
jnj:InvokanaMember
2019-09-29
0000200406
jnj:OpiodsMember
2019-09-29
0000200406
jnj:PinnacleAcetabularCupSystemMember
2019-09-29
0000200406
us-gaap:PendingLitigationMember
us-gaap:SubsequentEventMember
2019-10-31
0000200406
us-gaap:OtherRestructuringMember
jnj:MedicalDevicesMember
2018-12-31
2019-09-29
0000200406
us-gaap:EmployeeSeveranceMember
jnj:MedicalDevicesMember
2018-12-31
2019-09-29
0000200406
jnj:AssetWriteoffMember
jnj:MedicalDevicesMember
2018-12-31
2019-09-29
0000200406
us-gaap:OtherRestructuringMember
jnj:MedicalDevicesMember
2018-12-30
0000200406
jnj:MedicalDevicesMember
2018-12-31
2019-09-29
0000200406
jnj:AssetWriteoffMember
jnj:MedicalDevicesMember
2019-09-29
0000200406
jnj:AssetWriteoffMember
jnj:MedicalDevicesMember
2018-12-30
0000200406
jnj:MedicalDevicesMember
2019-09-29
0000200406
us-gaap:EmployeeSeveranceMember
jnj:MedicalDevicesMember
2018-12-30
0000200406
jnj:MedicalDevicesMember
2018-12-30
0000200406
us-gaap:EmployeeSeveranceMember
jnj:MedicalDevicesMember
2019-09-29
0000200406
us-gaap:OtherRestructuringMember
jnj:MedicalDevicesMember
2019-09-29
0000200406
srt:MinimumMember
jnj:SupplyChainMember
2019-09-29
0000200406
jnj:SupplyChainMember
2019-09-29
0000200406
us-gaap:CostOfSalesMember
jnj:SupplyChainMember
2018-12-31
2019-09-29
0000200406
jnj:SupplyChainMember
2019-07-01
2019-09-29
0000200406
srt:MaximumMember
jnj:SupplyChainMember
2019-09-29
0000200406
srt:MinimumMember
jnj:SupplyChainMember
jnj:MedicalDevicesMember
2018-12-31
2019-09-29
0000200406
jnj:OtherIncomeExpenseNetMember
jnj:SupplyChainMember
2019-07-01
2019-09-29
0000200406
srt:MaximumMember
jnj:SupplyChainMember
jnj:MedicalDevicesMember
2018-12-31
2019-09-29
0000200406
jnj:OtherIncomeExpenseNetMember
jnj:SupplyChainMember
2018-12-31
2019-09-29
0000200406
us-gaap:CostOfSalesMember
jnj:SupplyChainMember
2019-07-01
2019-09-29
0000200406
jnj:SupplyChainMember
2018-12-31
2019-09-29
xbrli:pure
xbrli:shares
iso4217:USD
xbrli:shares
iso4217:USD
iso4217:JPY
xbrli:shares
iso4217:JPY
jnj:patient
jnj:claimant
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
|
| | |
| | |
☑ | | Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
for the quarterly period ended September 29, 2019
or
|
| | |
| | |
☐ | | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to |
Commission file number 1-3215
Johnson & Johnson
(Exact name of registrant as specified in its charter)
|
| | |
New Jersey | | 22-1024240 |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) |
One Johnson & Johnson Plaza
New Brunswick, New Jersey 08933
(Address of principal executive offices)
Registrant’s telephone number, including area code (732) 524-0400
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☑ Yes ☐ No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☑ Yes ☐ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
|
| | | | |
| Large accelerated filer | ☑ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| Emerging growth company | ☐ | | |
If an emerging growth company, indicated by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☑ No
SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT
|
| | |
Title of each class | Trading Symbol | Name of each exchange on which registered |
Common Stock, Par Value $1.00 | JNJ | New York Stock Exchange |
4.75% Notes Due November 2019 | JNJ | New York Stock Exchange |
0.250% Notes Due January 2022 | JNJ | New York Stock Exchange |
0.650% Notes Due May 2024 | JNJ | New York Stock Exchange |
5.50% Notes Due November 2024 | JNJ | New York Stock Exchange |
1.150% Notes Due November 2028 | JNJ | New York Stock Exchange |
1.650% Notes Due May 2035 | JNJ | New York Stock Exchange |
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
On October 22, 2019, 2,631,872,399 shares of Common Stock, $1.00 par value, were outstanding.
JOHNSON & JOHNSON AND SUBSIDIARIES
TABLE OF CONTENTS
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q and Johnson & Johnson's other publicly available documents contain “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Management and representatives of Johnson & Johnson and its subsidiaries (the Company) also may from time to time make forward-looking statements. Forward-looking statements do not relate strictly to historical or current facts and reflect management’s assumptions, views, plans, objectives and projections about the future. Forward-looking statements may be identified by the use of words such as “plans,” “expects,” “will,” “anticipates,” “estimates,” and other words of similar meaning in conjunction with, among other things: discussions of future operations, expected operating results, financial performance; impact of planned acquisitions and dispositions; impact and timing of restructuring initiatives including associated cost savings and other benefits; the Company's strategy for growth; product development activities; regulatory approvals; market position and expenditures.
Because forward-looking statements are based on current beliefs, expectations and assumptions regarding future events, they are subject to uncertainties, risks and changes that are difficult to predict and many of which are outside of the Company's control. Investors should realize that if underlying assumptions prove inaccurate, or known or unknown risks or uncertainties materialize, the Company’s actual results and financial condition could vary materially from expectations and projections expressed or implied in its forward-looking statements. Investors are therefore cautioned not to rely on these forward-looking statements. Risks and uncertainties include, but are not limited to:
Risks Related to Product Development, Market Success and Competition
| |
• | Challenges and uncertainties inherent in innovation and development of new and improved products and technologies on which the Company’s continued growth and success depend, including uncertainty of clinical outcomes, additional analysis of existing clinical data, obtaining regulatory approvals, health plan coverage and customer access, and initial and continued commercial success; |
| |
• | Challenges to the Company’s ability to obtain and protect adequate patent and other intellectual property rights for new and existing products and technologies in the United States and other important markets; |
| |
• | The impact of patent expirations, typically followed by the introduction of competing biosimilars and generics and resulting revenue and market share losses; |
| |
• | Increasingly aggressive and frequent challenges to the Company’s patents by competitors and others seeking to launch competing generic, biosimilar or other products and increased receptivity of courts, the United States Patent and Trademark Office and other decision makers to such challenges, potentially resulting in loss of market exclusivity and rapid decline in sales for the relevant product sooner than expected; |
| |
• | Competition in research and development of new and improved products, processes and technologies, which can result in product and process obsolescence; |
| |
• | Competition to reach agreement with third parties for collaboration, licensing, development and marketing agreements for products and technologies; |
| |
• | Competition based on cost-effectiveness, product performance, technological advances and patents attained by competitors; and |
| |
• | Allegations that the Company’s products infringe the patents and other intellectual property rights of third parties, which could adversely affect the Company’s ability to sell the products in question and require the payment of money damages and future royalties. |
Risks Related to Product Liability, Litigation and Regulatory Activity
| |
• | Product efficacy or safety concerns, whether or not based on scientific evidence, potentially resulting in product withdrawals, recalls, regulatory action on the part of the United States Food and Drug Administration (or international counterparts), declining sales, reputational damage, increased litigation expense and share price impact; |
| |
• | Impact, including declining sales and reputational damage, of significant litigation or government action adverse to the Company, including product liability claims and allegations related to pharmaceutical marketing practices and contracting strategies; |
| |
• | Impact of an adverse judgment or settlement and the adequacy of reserves related to legal proceedings, including patent litigation, product liability, personal injury claims, securities class actions, government investigations, employment and other legal proceedings; |
| |
• | Increased scrutiny of the health care industry by government agencies and state attorneys general resulting in investigations and prosecutions, which carry the risk of significant civil and criminal penalties, including, but not limited to, debarment from government business; |
| |
• | Failure to meet compliance obligations in the McNEIL-PPC, Inc. Consent Decree or any other compliance agreements with governments or government agencies, which could result in significant sanctions; |
| |
• | Potential changes to applicable laws and regulations affecting United States and international operations, including relating to: approval of new products; licensing and patent rights; sales and promotion of health care products; access to, and reimbursement and pricing for, health care products and services; environmental protection and sourcing of raw materials; |
| |
• | Compliance with local regulations and laws that may restrict the Company’s ability to manufacture or sell its products in relevant markets including, requirements to comply with medical device reporting regulations and other requirements such as the European Union's Medical Devices Regulation; |
| |
• | Changes in domestic and international tax laws and regulations, including changes related to The Tax Cuts and Jobs Act in the United States, the Federal Act on Tax Reform and AHV Financing in Switzerland, increasing audit scrutiny by tax authorities around the world and exposures to additional tax liabilities potentially in excess of existing reserves; and |
| |
• | Issuance of new or revised accounting standards by the Financial Accounting Standards Board and regulations by the Securities and Exchange Commission. |
Risks Related to the Company’s Strategic Initiatives and Health Care Market Trends
| |
• | Pricing pressures resulting from trends toward health care cost containment, including the continued consolidation among health care providers and other market participants, trends toward managed care, the shift toward governments increasingly becoming the primary payers of health care expenses, significant new entrants to the health care markets seeking to reduce costs and government pressure on companies to voluntarily reduce costs and price increases; |
| |
• | Restricted spending patterns of individual, institutional and governmental purchasers of health care products and services due to economic hardship and budgetary constraints; |
| |
• | Challenges to the Company’s ability to realize its strategy for growth including through externally sourced innovations, such as development collaborations, strategic acquisitions, licensing and marketing agreements, and the potential heightened costs of any such external arrangements due to competitive pressures; |
| |
• | The potential that the expected strategic benefits and opportunities from any planned or completed acquisition or divestiture by the Company may not be realized or may take longer to realize than expected; and |
| |
• | The potential that the expected benefits and opportunities related to past and ongoing restructuring actions may not be realized or may take longer to realize than expected. |
Risks Related to Economic Conditions, Financial Markets and Operating Internationally
| |
• | Market conditions and the possibility that the Company’s share repurchase program may be delayed, suspended or discontinued; |
| |
• | Impact of inflation and fluctuations in interest rates and currency exchange rates and the potential effect of such fluctuations on revenues, expenses and resulting margins; |
| |
• | Potential changes in export/import and trade laws, regulations and policies of the United States and other countries, including any increased trade restrictions or tariffs and potential drug reimportation legislation; |
| |
• | The impact on international operations from financial instability in international economies, sovereign risk, possible imposition of governmental controls and restrictive economic policies, and unstable international governments and legal systems; |
| |
• | Changes to global climate, extreme weather and natural disasters that could affect demand for the Company's products and services, cause disruptions in manufacturing and distribution networks, alter the availability of goods and services within the supply chain, and affect the overall design and integrity of the Company's products and operations; and |
| |
• | The impact of armed conflicts and terrorist attacks in the United States and other parts of the world including social and economic disruptions and instability of financial and other markets. |
Risks Related to Supply Chain and Operations
| |
• | Difficulties and delays in manufacturing, internally through third party providers or otherwise within the supply chain, that may lead to voluntary or involuntary business interruptions or shutdowns, product shortages, withdrawals or suspensions of products from the market, and potential regulatory action; |
| |
• | Interruptions and breaches of the Company's information technology systems or those of the Company's vendors which, could result in reputational, competitive, operational or other business harm as well as financial costs and regulatory action; |
| |
• | Reliance on global supply chains and production and distribution processes that are complex and subject to increasing regulatory requirements that may adversely affect supply, sourcing and pricing of materials used in the Company’s products; and |
| |
• | The potential that the expected benefits and opportunities related to restructuring actions contemplated for the global supply chain may not be realized or may take longer to realize than expected, including due to any required approvals from applicable regulatory authorities. Disruptions associated with the announced global supply chain actions may adversely affect supply and sourcing of materials used in the Company's products. |
Investors also should carefully read the Risk Factors described in Item 1A of the Company's Annual Report on Form 10-K for the fiscal year ended December 30, 2018, for a description of certain risks that could, among other things, cause the Company’s actual results to differ materially from those expressed in its forward-looking statements. Investors should understand that it is not possible to predict or identify all such factors and should not consider the risks described above to be a complete statement of all potential risks and uncertainties. The Company does not undertake to publicly update any forward-looking statement that may be made from time to time, whether as a result of new information or future events or developments.
Part I — FINANCIAL INFORMATION
Item 1 — FINANCIAL STATEMENTS
JOHNSON & JOHNSON AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Unaudited; Dollars in Millions Except Share and Per Share Data)
|
| | | | | | | |
| | September 29, 2019 | | December 30, 2018 |
ASSETS |
Current assets: | | | | |
Cash and cash equivalents | | $ |
|